Preliminary data from France, Belgium, and Bahrain shows that hydroxychloroquine can have a dramatic life-saving effect on patients with Covid-19, yet two governors have banned it’s use in their states. We shall see how they react now that the FDA has given emergency approval for the use of the anti-malaria drug for use in Covid-19 patients.
John Soloman from Just the News reports:
The Food and Drug Administration on Sunday gave doctors emergency permission to use the anti-malarial drugs hydroxychloroquine and chloroquine to treat the coronavirus.
The agency’s action allows the medicines “to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible,” according to a Department of Health and Human Services statement.
Although there are no currently approved treatments for COVID-19, both drugs have shown activity in laboratory studies against coronaviruses, including SARS-CoV-2 (the virus that causes COVID-19). Anecdotal reports suggest that these drugs may offer some benefit in the treatment of hospitalized COVID-19 patients. Clinical trials are needed to provide scientific evidence that these treatments are effective,
HHS said in making the announcement.
Officials also announced that two drugmakers, Sandoz and Bayer, had donated 31 million doses of the two medicines to the government’s emergency stockpile to be used by doctors.
